Medicines are of great value to health care and society. ZonMw research into existing medicines is directed towards their more effective, more efficient, and safer use in day-to-day health care. Widespread dissemination and practical application of the generated knowledge is crucial to delivering health benefits to patients, improving the quality of care, and saving unnecessary costs.
The optimal use of existing medicines is an innovative area of work that shows great promise for the coming years.
ZonMw selected two challenges for ‘proof of concept’ projects of Create2Solve. With Create2Solve, ZonMw makes funding available to research organisations and SMEs (small and medium-sized enterprises) for the development of animal-free innovations within the program More Knowledge with Fewer Animals. This call for demand-driven innovations is now open for proposals. On 22 August, ZonMw will organise a webinar for any interested parties who want to...
On Friday 21 June, Monique den Boer from the Princess Máxima Center received the second ZonMw Open Science Boost. Radjesh Manna, director of programmes at ZonMw, handed her the prize during a surprise visit to Utrecht. Monique den Boer, Professor of Molecular Pediatric Leukemia, together with her research group, made a big contribution to the objectives of open science: responsive, transparent, and responsible science. With this boost, ZonMw...
The AAL Call 2019 focused on “Sustainable Smart Solutions for Ageing well” was closed on 24 May. The Call, which is the 12th one published by the Programme since its inception in 2008, received 82 applications, out of which 57 were collaborative projects and 25 were small collaborative projects. Following the central eligibility check, 81 applications were admitted to the evaluation.
Research within the following research areas is eligible for funding in this round:
Studies on how to prevent the acquisition and / or transmission of antibacterial resistant bacteria, or ABR genes in different environments according to One Health e.g., patients, hospitals, farms, nature, etc.
Studies that support appropriate (use of) diagnostics.
Studies that support new or improved applications for antibiotics and alternatives to antibiotics.
Studies on optimising dosage and prudent use of antibiotics.
Facilitate the dissemination of unique technological expertise in the Netherlands to other research groups/institutions/companies that have not worked with that technology before;
To stimulate novel interactions among research groups and Technology Hotels and thereby contribute to the advancement of the used technology;
To encourage the use of advanced life sciences technologies in public-private partnerships;
Propagate the use of data stewardship and data integration principles, methods and standards in advanced life sciences research projects.
